RICCI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 18.576
AS - Asia 3.294
EU - Europa 2.226
SA - Sud America 471
AF - Africa 358
OC - Oceania 271
Continente sconosciuto - Info sul continente non disponibili 5
Totale 25.201
Nazione #
US - Stati Uniti d'America 18.410
SG - Singapore 1.090
CN - Cina 598
RU - Federazione Russa 356
BR - Brasile 348
DE - Germania 326
IN - India 300
IT - Italia 282
AU - Australia 264
GB - Regno Unito 257
HK - Hong Kong 236
ID - Indonesia 227
UA - Ucraina 218
IE - Irlanda 213
VN - Vietnam 199
FR - Francia 166
SE - Svezia 89
MX - Messico 80
PL - Polonia 77
KR - Corea 76
JP - Giappone 73
FI - Finlandia 67
CA - Canada 61
PK - Pakistan 60
NG - Nigeria 59
PH - Filippine 56
GH - Ghana 54
ZA - Sudafrica 51
TR - Turchia 49
KE - Kenya 46
TH - Thailandia 45
MY - Malesia 44
EG - Egitto 38
NL - Olanda 37
TW - Taiwan 36
ET - Etiopia 34
BD - Bangladesh 33
IQ - Iraq 33
AR - Argentina 30
EC - Ecuador 22
SA - Arabia Saudita 20
NP - Nepal 19
BE - Belgio 18
ES - Italia 18
IR - Iran 17
CL - Cile 16
LT - Lituania 16
AT - Austria 13
CO - Colombia 13
IL - Israele 13
MU - Mauritius 13
PE - Perù 13
VE - Venezuela 12
KG - Kirghizistan 11
MA - Marocco 10
PT - Portogallo 10
RO - Romania 10
UG - Uganda 10
MG - Madagascar 9
NO - Norvegia 9
PY - Paraguay 7
UZ - Uzbekistan 7
ZM - Zambia 7
EE - Estonia 6
KH - Cambogia 6
MW - Malawi 6
NZ - Nuova Zelanda 6
AZ - Azerbaigian 5
BO - Bolivia 5
CM - Camerun 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
JO - Giordania 5
LV - Lettonia 5
TZ - Tanzania 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
DK - Danimarca 4
DZ - Algeria 4
EU - Europa 4
GR - Grecia 4
MM - Myanmar 4
NI - Nicaragua 4
QA - Qatar 4
TN - Tunisia 4
AL - Albania 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KW - Kuwait 3
KZ - Kazakistan 3
PA - Panama 3
BG - Bulgaria 2
BT - Bhutan 2
BY - Bielorussia 2
CR - Costa Rica 2
DM - Dominica 2
JM - Giamaica 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
Totale 25.172
Città #
Woodbridge 4.669
Wilmington 4.383
Houston 4.365
Singapore 650
Fairfield 506
Ashburn 418
Ann Arbor 393
Chandler 377
San Jose 273
Seattle 245
Beijing 198
Dublin 198
Cambridge 197
Hong Kong 192
Jacksonville 186
Medford 160
Dearborn 140
New York 139
Los Angeles 103
Perth 92
The Dalles 91
Santa Clara 89
Rome 88
Boardman 72
Lawrence 72
Moscow 70
Ho Chi Minh City 69
Jakarta 63
Tokyo 63
Council Bluffs 60
Melbourne 54
Zhengzhou 53
Kraków 49
Lauterbourg 48
Hanoi 44
Sydney 44
Buffalo 43
Chennai 43
Munich 43
Nairobi 41
São Paulo 41
Bangkok 40
Accra 36
Dallas 32
Milan 32
San Diego 32
Chicago 29
Mülheim 26
Shanghai 25
London 23
Montreal 23
Kuala Lumpur 22
Malang 22
Waurn Ponds 22
Menlo Park 21
Orem 21
San Francisco 20
Bengaluru 19
Manila 19
Mexico City 19
Cairo 18
Guangzhou 18
Helsinki 18
Manchester 18
Nuremberg 18
Brussels 17
Hyderabad 17
Phoenix 17
Abuja 16
Baghdad 16
Lagos 16
Mumbai 16
North Bergen 16
Riyadh 16
Warsaw 16
Bodorgan 15
Shenzhen 15
Taipei 15
Johannesburg 14
Karachi 14
Kathmandu 14
Lahore 14
Nanjing 14
Pune 14
Rio de Janeiro 14
Denpasar 13
Dhaka 13
Frankfurt am Main 13
Aksum 12
Birmingham 12
Boston 12
Delhi 12
Istanbul 12
Kansas City 12
Kolkata 12
New Delhi 12
Redondo Beach 12
Redwood City 12
Bandung 11
Mthatha 11
Totale 20.184
Nome #
A literature review of hypertensive retinopathy: systemic correlations and new technologies 2.396
Validity and limitations of the Nidek NT-4000 non-contact tonometer: a clinical study 516
CLU "in and out": looking for a link. 504
Review of nutrient actions on age-related macular degeneration 503
Visual disability and quality of life in glaucoma patients 502
Electro-oculography in pigment dispersion syndrome 495
Assessment of the retinal posterior pole in dominant optic atrophy by spectral-domain optical coherence tomography and microperimetry. 491
Age-related macular degeneration: insights into inflammatory genes 485
Clusterin in stool: a new biomarker for colon cancer screening? 483
Automatic Segmentation of Posterior Pole Retinal Layers In Patients with Early Stage Glaucoma Using Spectral Domain Optical Coherence Tomography 474
Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage 467
Age-specific changes in the prevalence and management of optically correctable visual impairment between 1988 and 2000: the Ponza Eye Study 465
Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage 457
Long-term functional and morphologic retinal changes after ranibizumab and photodynamic therapy in myopic choroidal neovascularization 454
Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon 454
Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks 447
The 12-year Incidence of Glaucoma and Glaucoma-related Visual Field Loss in Italy: The Ponza Eye Study 445
Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy 445
Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population 442
Prevalence of blindness and low vision in an Italian population: A comparison with other European studies 440
Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab 438
Age-specific changes in the prevalence of best-corrected visual impairment in an italian population 438
Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinpathy (AZOOR) with adalimumab (Humira™). 435
Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy 434
Compassionate use of intravitreal pegaptanib in patients with age-related macular degeneration 431
Evaluation of pupillary response to light in patients with glaucoma: a study using computerized pupillometry 429
Low contrast visual acuity in pseudophakic patients implanted with an anterior surface modified prolate intraocular lens 424
Incidence of visual loss in the Ponza Eye Study, Italy 418
Prevalence and risk factors of vision impairment among children of employees of Telecom, Italy. 416
CLU "in and out": looking for a link 415
Assessing individual risk for AMD with genetic counseling, family history, and genetic testing 415
Nationwide incidence of endophthalmitis among the general population and the subjects at risk of endophthalmitis in Italy 412
Clusterin in stool: a new biomarker for colon cancer screening? 411
Prevalence and incidence of age-related cataract in a population sample from Priverno, Italy. Ophthalmic Epidemiol. 1999 Jun;6(2):95-103. 409
Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon 407
ICGA Guided Low-fluence Photodynamic Therapy Combined With PRN Ranibizumab For Active Polypoidal Choroidal Vasculopathy 402
Persistent epithelial defect after penetrating keratoplasty caused by adenoviral infectious keratitis 397
Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study 397
Evaluation of fixation stability using different targets with the MP1 microperimeter 390
Polymorphisms in ARMS2 (LOC387715) and LOXL1 genes in the Japanese with age-related macular degeneration 371
Monolateral Corectopia: considerations about associated myopia. A case report. 369
Indocyanine green angiography and optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration 337
L’epidemiologia del glaucoma 332
Moorfields Regression Analysis (MRA) and Glaucoma Probability Score (GPS) Agreement in Daily Clinical Practice 319
OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization 319
Towards the application of precision medicine in age-related macular degeneration 312
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: The RETAIN study 282
The Interplay between miRNA-Related Variants and Age-Related Macular Degeneration: EVIDENCE of Association of MIR146A and MIR27A. 273
Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: Significant association of twelve variants 260
Using real-world data to estimate the Social Security Costs of Retinal Diseases: Results from the Observatory on Legal Blindness 243
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration: A Phase IIb, Multicenter, Randomized Controlled Trial 228
Ultrasound-Guided Vacuum-Assisted Biopsy in Small Breast: A Cost-Saving Solution 209
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 204
Bilateral Retinal Angiomatous Proliferation in a Variant of Retinitis Pigmentosa 201
Platelet-rich plasma as treatment for persistent ocular epithelial defects 163
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri phase 3 randomized clinical trials 97
Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data 93
A cluster of presumed, noninfectious endophthalmitis after intravitreal injection of bevacizumab: long-term follow-up 92
Antimicrobial activity on contact lenses contaminated with planktonic and sessile forms of bacteria: An experimental approach 90
Thickness mapping of individual retinal layers and sectors by Spectralis Spectral Domain-optical Coherence Tomography in Autosomal Dominant Optic Atrophy 88
Definition of indicators of appropriateness in the management of neovascular age-related macular degeneration: An expert opinion 86
Optical coherence tomography angiography in the multimodal assessment of the retinal posterior pole in autosomal dominant optic atrophy 85
Aflibercept in persistent neovascular AMD: Comparison of different treatment strategies in switching therapy 83
Epigenomic signatures in age-related macular degeneration: Focus on their role as disease modifiers and therapeutic targets 82
Ranibizumab for visual impairment due to diabetic macular edema: Real-world evidence in the Italian population (pride study) 80
Genetic determinants highlight the existence of shared etiopathogenetic mechanisms characterizing age-related macular degeneration and neurodegenerative disorders 78
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases 69
An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification 67
Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study 65
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial 63
Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration 62
Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach 59
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study 58
Neovascular age-related macular degeneration: Therapeutic management and new-upcoming approaches 57
Paper card-like electrochemical platform as a smart point-of-care device for reagent-free glucose measurement in tears 55
Effectiveness of anti-vascular endothelial growth factors in neovascular age-related macular degeneration and variables associated with visual acuity outcomes: Results from the EAGLE study 55
Longitudinal Structural and Functional Evaluation of Dark-without-Pressure Fundus Lesions in Patients with Autoimmune Diseases 53
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations 53
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 36
Correction: Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries (Eye, (2023), 37, 16, (3351-3359), 10.1038/s41433-023-02540-w) 34
Totale 25.445
Categoria #
all - tutte 60.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021273 0 0 0 0 0 0 0 0 0 115 125 33
2021/2022703 14 42 46 26 12 55 120 30 36 53 83 186
2022/2023962 105 81 24 100 104 211 75 93 84 2 60 23
2023/20241.066 91 45 70 71 99 172 88 60 70 72 49 179
2024/20252.751 132 428 270 145 150 191 247 204 276 205 291 212
2025/20263.450 395 159 458 413 290 183 353 500 485 214 0 0
Totale 25.445